(Q47581984)

4 February 2018

title

Immune Reconstitution and Early Infectious Complications Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (English)

1 reference

https://api.crossref.org/works/10.1080/10245330310001612125

18 March 2024

11

1 reference

4 February 2018

Franco Locatelli

4

object named as

Franco Locatelli

1 reference

4 February 2018

Alessandro Busca

1

object named as

Alessandro Busca

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14530172

18 March 2024

author name string

Elisabetta Lovisone

2

1 reference

4 February 2018

Sabrina Aliberti

3

1 reference

4 February 2018

Anna Serra

5

1 reference

4 February 2018

Patrizia Scaravaglio

6

1 reference

4 February 2018

Paola Omedè

7

1 reference

4 February 2018

Giuseppe Rossi

8

1 reference

4 February 2018

Daniela Cirillo

9

1 reference

4 February 2018

Anna Barbui

10

1 reference

4 February 2018

Anna Maria Dall'Omo

12

1 reference

4 February 2018

Michele Falda

13

1 reference

4 February 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14530172

18 March 2024

publication date

1 October 2003

1 reference

4 February 2018

full work available at URL

https://www.tandfonline.com/doi/pdf/10.1080/10245330310001612125

1 reference

https://api.crossref.org/works/10.1080/10245330310001612125

18 March 2024

1 reference

4 February 2018

volume

8

1 reference

4 February 2018

issue

5

1 reference

4 February 2018

page(s)

303-311

1 reference

4 February 2018

Solid cancers after bone marrow transplantation.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

CMV reactivation in nonmyeloablative HSCT

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330310001612125

Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1080/10245330310001612125

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

18 March 2024

3

1 reference

https://api.crossref.org/works/10.1080/10245330310001612125

18 March 2024

Identifiers

1 reference

4 February 2018

1 reference

4 February 2018